title: Developmental toxicity of Citrus aurantium in rats.
abstract: BACKGROUND
  Ephedra was commonly used in herbal products marketed for weight loss until safety concerns forced its removal from products. Even before the ban, manufacturers had begun to replace ephedra with other compounds, including Citrus aurantium, or bitter orange. The major component in the bitter orange extract is synephrine which is chemically similar to ephedrine. The purpose of this study was to determine if relatively pure synephrine or synephrine present as a constituent of a bitter orange extract produced developmental toxicity in rats.
  
  
  METHODS
  Sprague-Dawley rats were dosed daily by gavage with one of several different doses of synephrine from one of two different extracts. Caffeine was added to some doses. Animals were sacrificed on GD 21, and fetuses were examined for the presence of various developmental toxic endpoints.
  
  
  CONCLUSIONS
  At doses up to 100 mg synephrine/kg body weight, there were no adverse effects on embryolethality, fetal weight, or incidences of gross, visceral, or skeletal abnormalities. There was a decrease in maternal weight at 50 mg synephrine/kg body weight when given as the 6% synephrine extract with 25 mg caffeine/kg body weight; there was also a decrease in maternal weight in the caffeine only group. This decrease in body weight may have been due to decreased food consumption which was also observed in these two groups. Overall, doses of up to 100 mg synephrine/kg body weight did not produce developmental toxicity in Sprague-Dawley rats.
authors: Division of Personalized Nutrition and Medicine, NCTR/FDA, Jefferson, Arkansas. deborah.hansen@fda.hhs.gov
authors: Deborah K
authors: DK
authors: Hansen
authors: Beth E
authors: BE
authors: Juliar
authors: Gene E
authors: GE
authors: White
authors: Linda S
authors: LS
authors: Pellicore
references: Life Sci. 1995;56(21):1767-78
references: 7739351
references: N Engl J Med. 2000 Dec 21;343(25):1833-8
references: 11117974
references: Food Chem Toxicol. 2004 Dec;42(12):1923-30
references: 15500929
references: J Agric Food Chem. 2003 Sep 10;51(19):5630-8
references: 12952412
references: Teratog Carcinog Mutagen. 1984;4(2):181-8
references: 6145223
references: Toxicol Lett. 1985 Dec;29(1):65-8
references: 4082207
references: Am J Obstet Gynecol. 2010 May;202(5):443.e1-6
references: 20035911
references: Birth Defects Res A Clin Mol Teratol. 2008 Aug;82(8):553-62
references: 18553492
references: JAMA. 2003 Mar 26;289(12):1537-45
references: 12672771
references: Exp Biol Med (Maywood). 2004 Sep;229(8):698-704
references: 15337824
references: Dev Growth Differ. 1997 Aug;39(4):505-14
references: 9352205
references: Am J Obstet Gynecol. 2010 May;202(5):439.e1-439.e10
references: 20452484
references: Science. 2003 Sep 19;301(5640):1669-71; author reply 1669-71
references: 14500960
references: Toxicol Lett. 1985 Dec;29(1):59-63
references: 4082206
references: Atti Accad Med Lomb. 1970;25(2-3):203-7
references: 5538534
references: Am J Cardiol. 2004 Nov 15;94(10):1359-61
references: 15541270
references: J Am Diet Assoc. 2005 Jan;105(1):110-3
references: 15635355
references: Surg Gynecol Obstet. 1969 Sep;129(3):556-64
references: 5387698
references: Ann Pharmacother. 2006 Oct;40(10):1747-51
references: 16968826
references: J Chromatogr Sci. 2008 Jan;46(1):61-7
references: 18218190
references: J Am Diet Assoc. 2006 Dec;106(12):2045-51
references: 17126636
references: Obesity (Silver Spring). 2008 Apr;16(4):790-6
references: 18239570
references: J Am Diet Assoc. 2007 Mar;107(3):441-7
references: 17324663
references: Birth Defects Res B Dev Reprod Toxicol. 2007 Dec;80(6):451-72
references: 18157900